Home News

ROVI completes the manufacture of the first batches of Moderna vaccine

Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the research, development and marketing of biological specialties and a manufacturer with a high degree of technological

Wed, 13/01/2021 - 17:03 0 min
Download related document
No votes yet
 
Related
ROVI holds its 2020 General Shareholders' Meeting
ROVI holds its 2020 General Shareholders' Meeting
Today, Laboratorios Farmacéuticos Rovi, S.A. held its General Shareholders’ Meeting, where the year 2019, marked by significant growth, was...
5 min
20/10/2020
ROVI Rating ESG 2020
0 min
25/09/2020
ROVI obtains second place in a global sustainability rating
ROVI obtains second place in a global sustainability rating
ROVI participated voluntarily in this rating, which measures the sustainability of companies based on criteria such as corporate governance...
1 min
25/09/2020